Haemonetics Corporation remains a high-quality blood-management franchise with strong TEG and plasma software moats, but recent growth has paused due to portfolio shifts and competition. Q1 FY2026 results beat expectations on margins and cash flow, but headline revenue declined due to deliberate exits and one-time factors boosting growth. HAE valuation is compelling at ~11x forward EPS and ~8x EV/EBITDA, with strong FCF and margin expansion offering attractive upside if execution improves.

Monday.com (NASDAQ:MNDY) shares tumbled almost 27% despite the productivity software-maker's second quarter earnings beating expectations as it issued somewhat cautious guidance for Q3. The company's Q3 revenue guidance of about $311 to $313 million was slightly below analyst expectations at the midpoint.

AMAT's third-quarter fiscal 2025 performance is likely to grow on the back of AI-driven chip demand, but trade tensions can weigh on results.

Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Grocery Outlet Holding Corp. (GO) or Church & Dwight (CHD). But which of these two companies is the best option for those looking for undervalued stocks?

Investors interested in stocks from the Computer - Integrated Systems sector have probably already heard of Hewlett Packard Enterprise (HPE) and Silicon Motion (SIMO). But which of these two stocks is more attractive to value investors?

Investors with an interest in Medical Services stocks have likely encountered both CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors?

Investors with an interest in Banks - Foreign stocks have likely encountered both Woori Bank (WF) and Canadian Imperial Bank (CM). But which of these two stocks presents investors with the better value opportunity right now?

Investors interested in Financial - Miscellaneous Services stocks are likely familiar with Grupo Financiero Banorte SAB de CV (GBOOY) and Blackstone Inc. (BX). But which of these two companies is the best option for those looking for undervalued stocks?

Investors interested in Food - Miscellaneous stocks are likely familiar with Ingredion (INGR) and Danone (DANOY). But which of these two companies is the best option for those looking for undervalued stocks?

Investors interested in stocks from the Manufacturing - Electronics sector have probably already heard of EnerSys (ENS) and Emerson Electric (EMR). But which of these two stocks offers value investors a better bang for their buck right now?

Investors interested in stocks from the Financial Transaction Services sector have probably already heard of PagSeguro Digital Ltd. (PAGS) and Shift4 Payments (FOUR).

Investors interested in stocks from the Paper and Related Products sector have probably already heard of Suzano S.A. Sponsored ADR (SUZ) and Klabin SA (KLBAY).

Investors with an interest in Medical - Drugs stocks have likely encountered both Sandoz Group AG Sponsored ADR (SDZNY) and Zoetis (ZTS). But which of these two companies is the best option for those looking for undervalued stocks?

Major U.S. equities indexes were little changed in recent trading ahead of key corporate earnings and inflation data due later in the week.

Excelerate Energy, Inc. (NYSE:EE ) Q2 2025 Earnings Conference Call August 11, 2025 8:30 AM ET Company Participants Craig Hicks - Vice President of Investor Relations & ESG Dana A. Armstrong - Executive VP & CFO David A.

Chip stocks are rising to start the week. The reasons range from upbeat indications about demand to hopes of peace with Washington.

Trinity Capital offers a double-digit, well-covered 12.9% dividend yield. The BDC reported NAV per share growth of 22 cents sequentially for its second quarter. TRIN's payout ratio also improved sequentially following NII that grew by 30.3% over its year-ago comp.

MRK trims its 2025 sales range but lifts the lower end of its EPS outlook. Keytruda, Animal Health and new drugs are expected to drive a second-half rebound.

SD posts strong Q2 results with higher output, lower costs and boosted dividends despite softer oil prices.

Vitesse Energy is rated a buy, trading 36% below fair value, with strong deleveraging and robust earnings growth projected through 2026. Q2 2025 saw record revenue and production growth, with effective hedging strategies stabilizing future cash flows and protecting against oil price volatility. VTS's forward EV/EBITDA and peer comparison highlight its undervaluation, high dividend yield, and improving net debt metrics versus industry peers.